Channel address:
Categories:
Economics ,
Investments
Language: English
Country: Not set
Subscribers:
141.03K
Description from channel
Creating wealth through unfolded research.
SEBI Registered Investment Adviser
Reg No - INA000005358
Disclaimer: Channel view is purely for educational purposes.
Visit our website https://Equity99.com
Ratings & Reviews
Reviews can be left only by registered users. All reviews are moderated by admins.
5 stars
1
4 stars
1
3 stars
0
2 stars
0
1 stars
1
The latest Messages 573
2021-06-08 11:48:06
Special Situations Stock
PSU STOCKS IN FLAVOUR
UNTOUCH PSU STOCK
MIDHANI
Cmp 205
Test Levels 215---220---225
Sl 197
Short Term / Coming Days view
30.0K views08:48
2021-06-08 10:38:31
Special Situations Stock J M FINANCIAL Cmp 85 Test Levels 89---92 Sl 81 Short Term / Coming Days view
37.9K views07:38
2021-06-08 09:44:18
MultiBagger Potential Take Solutions 71 / 72 TAKE Solutions is a technology driven, full service Clinical Research Organization. It helps biopharma companies throughout the drug development process, and beyond & it constitutes 94% of company`s revenue.…
43.0K views06:44
2021-06-08 09:30:42
Ready To Break Near 73 Hit New High 71.95
43.2K viewsedited 06:30
2021-06-08 09:22:46
Multiyear Breakout
Look @ daily chart of TAKE SOLUTIONS....Range break & breal out retest....Now expect non stop rally from here
Once Break Out Above 73 Expected Sharp Upside Move Upto 80
43.2K views06:22
2021-06-08 09:17:02
MultiBagger Potential
Take Solutions 71 / 72
TAKE Solutions is a technology driven, full service Clinical Research Organization. It helps biopharma companies throughout the drug development process, and beyond & it constitutes 94% of company`s revenue. Headquartered in Chennai, India, it has a global footprint spanning the Americas, Europe and the Asia Pacific region. It has 1,70,000 regulatory submissions and submitted 5% of all regulatory submissions to USFDA 2012 to 2020.
*Geographical Split*
USA: 85% in FY 20 vs 80% in FY17
Asia-Pacific: 13% in FY20
Europe: 2% in FY20 vs 7% in FY17
*Cliental Base*
The Co. had about 400 active clients at the end of FY20. Some of their clients are Pfizer Inc, Celgene Corporation, Mylan N.V, Dr. Reddy’s Laboratories, etc. Top 10 customers contribute only 24% of the overall revenue. 90% of the business is from the same set of clients.
*Recent Cost Cutting Measures*
The Co. has Shut down Europe business during Q1 of FY 21 because it wasn't generating cash, which in turn decreased SG&A expenses from about Rs 185 Cr a quarter in FY20 to around Rs 37 Cr a quarter in FY 21.
*Recent Orders*
Till Sep 20, Company has won 3 contracts worth more than Rs 14 Cr each and won another 3 contracts worth more than Rs 7 Cr each. The Co. has signed exclusive strategic partnership with 2 SME biotech to take over their complete drug Trial portfolio. It has signed a 5-year contract for PV technology and services A top 5 pharmaceutical renewed a Rs 37 Cr contract.
43.8K viewsedited 06:17
2021-06-08 09:00:47
Special Situations Stock( High Conviction ) Take solutions Cmp 70 / 71 Test Levels 80 / 90 / 100 Sl 60 Once Break Out Above 75 We Expected Move Like Adani Power Our Previous Research
43.5K views06:00
2021-06-08 08:56:39
Special Situations Stock( High Conviction )
Take solutions Cmp 70 / 71
Test Levels 80 / 90 / 100
Sl 60
Once Break Out Above 75 We Expected Move Like Adani Power Our Previous Research
44.3K views05:56
2021-06-08 08:47:45
Special Situations Stock ( High Conviction )
GPPL Cmp 111-111.5
Test Levels 117---123
Sl 107
Coming Days view Short Term View
45.1K views05:47
2021-06-08 08:30:28
Special Situations Stock ( High Conviction )
Aptech Ltd Cmp 263 / 264
Test Levels 300 / 330
Sl 230
Coming Days view Short Term View
46.5K viewsedited 05:30
E
